+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hydrophilic Coronary Stents Market - Global Forecast 2026-2032- Product Image
Hydrophilic Coronary Stents Market - Global Forecast 2026-2032- Product Image
Sale

Hydrophilic Coronary Stents Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122588
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hydrophilic Coronary Stents Market is projected to reach USD 1.42 Billion in 2026. It is expected to continue growing at a CAGR of 6.81%, reaching USD 2.09 Billion by 2032.

Hydrophilic Coronary Stents: Executive Overview

Hydrophilic coronary stents are designed with surface treatments that improve wettability and may support smoother delivery through complex vascular anatomy. Their clinical relevance is closely tied to percutaneous coronary intervention, where physicians balance deliverability, lesion access, radial strength, restenosis prevention, thrombosis risk, and antiplatelet-management requirements. Adoption is shaped by clinical evidence, regulatory authorization, reimbursement, hospital procurement standards, and operator familiarity rather than by coating technology alone.

Clinical and Procedural Shifts Reshaping Hydrophilic Stent Use

The landscape is shifting toward patient-specific intervention, greater use of minimally invasive procedures, and more demanding treatment of calcified, tortuous, and long lesions. These changes increase the importance of stent trackability, crossing performance, deployment control, and compatibility with contemporary imaging and lesion-preparation techniques. Evidence expectations are also broadening: stakeholders increasingly assess outcomes across patient risk groups, procedural complexity, bleeding considerations, and long-term vessel performance. Sustainability, supply resilience, training, and total procedural value are becoming relevant alongside device specifications.

Artificial Intelligence’s Cumulative Impact on Stent Selection and Care

Artificial intelligence can influence this field through image interpretation, lesion characterization, procedural planning, and post-intervention monitoring. When validated and integrated into clinical workflows, AI may help identify anatomical features associated with difficult device delivery, support more consistent assessment of lesion severity, and improve documentation of procedural outcomes. Its value depends on representative clinical data, transparent validation, interoperability with imaging and hospital systems, and clear human oversight. AI does not replace physician judgment; it can strengthen decision support when regulatory, privacy, and cybersecurity requirements are addressed.

Regional Insights Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America is characterized by mature interventional-cardiology infrastructure, extensive clinical evidence requirements, and strong emphasis on device safety, outcomes, and hospital value analysis. Europe combines advanced tertiary care with varied national reimbursement and procurement systems, making evidence transfer and country-specific access important. Asia-Pacific includes highly developed intervention centers alongside rapidly expanding cardiovascular-care capacity, with local regulatory pathways, affordability, and training influencing adoption. Latin America is shaped by unequal access to catheterization laboratories, public-private healthcare differences, and import and reimbursement conditions. The Middle East generally shows concentration of advanced care in major urban and referral centers, while Africa faces substantial infrastructure, specialist-access, and affordability constraints; both regions can benefit from training partnerships and dependable supply arrangements.

Group Insights: ASEAN, BRICS, European Union, G7, GCC, and NATO

ASEAN markets differ considerably in healthcare financing, regulatory maturity, and access to interventional facilities, creating a need for adaptable distribution and clinical-education models. BRICS members span large and diverse patient populations, with domestic manufacturing policy, public procurement, and uneven specialist capacity influencing device access. The European Union benefits from regulatory coordination but retains meaningful differences in reimbursement, hospital purchasing, and clinical practice. G7 systems generally emphasize rigorous evidence, quality assurance, and cost-effectiveness within established cardiovascular networks. GCC countries often have concentrated, well-equipped referral centers and may prioritize advanced technologies alongside workforce development. NATO membership is not a healthcare market category, but its members commonly include sophisticated hospital systems where resilience, procurement governance, and continuity of medical-device supply are material considerations.

Country Insights: Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the UK, and the US

Australia and Canada combine advanced specialist care with geographically uneven access and structured public assessment. Brazil and Mexico reflect large, heterogeneous healthcare systems in which reimbursement, public procurement, and regional catheterization capacity are important. China and India have substantial cardiovascular-care needs, but adoption varies by hospital tier, regulatory requirements, domestic production policies, and affordability. Japan and South Korea maintain sophisticated intervention capabilities with strong attention to clinical standards and local approval processes. France, Germany, Italy, Spain, and the United Kingdom operate within mature European frameworks while differing in reimbursement, procurement, and evidence implementation. The United States places strong emphasis on regulatory evidence, hospital economics, and outcomes-based practice. Russia’s healthcare access and procurement environment is influenced by regulatory, economic, and geopolitical conditions, requiring careful assessment of supply continuity and clinical infrastructure.

Actionable Priorities for Leaders in Hydrophilic Coronary Stents

Leaders should define a differentiated clinical value proposition around deliverability, procedural efficiency, safety, and outcomes in clearly characterized lesion and patient groups. They should generate high-quality evidence using transparent endpoints, appropriate comparators, real-world follow-up, and subgroup analyses relevant to complex interventions. Regulatory and reimbursement planning should be localized, particularly where approval, coding, procurement, and health-technology-assessment requirements diverge. Partnerships with hospitals and clinical educators can support responsible adoption through training, imaging integration, and standardized procedural protocols. Finally, organizations should strengthen supplier resilience, cybersecurity, post-market surveillance, and data governance while using AI only where performance is clinically validated and accountable.

Research Methodology for the Hydrophilic Coronary Stents Executive Summary

This summary uses a structured qualitative synthesis of established clinical, regulatory, healthcare-delivery, and technology considerations relevant to hydrophilic coronary stents. The framework evaluates procedural needs, evidence expectations, regional healthcare conditions, group-level policy and infrastructure patterns, country-specific access factors, and the potential role of AI. Insights are framed without market estimates, market shares, forecasts, or company-specific claims. Because conditions vary by indication, jurisdiction, and care setting, individual regulatory decisions, reimbursement determinations, and clinical choices require confirmation through current primary sources and local expert review.

Conclusion: Competing Through Evidence, Access, and Procedural Value

Hydrophilic coronary stents sit within a demanding interventional environment where technical performance must translate into reliable clinical and economic value. The strongest strategies will connect device design with evidence in complex procedures, localized access planning, operator training, resilient supply, and responsible digital integration. Regional and country differences make a uniform approach ineffective. Leaders that prioritize validated outcomes, transparent communication, and patient-centered implementation will be better positioned to support appropriate adoption across diverse healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Hydrophilic Coronary Stents Market, by Stent Type
7.1. Introduction
7.2. Bare-Metal Stent
7.3. Drug-Eluting Stent
8. Hydrophilic Coronary Stents Market, by Drug Type
8.1. Introduction
8.2. Everolimus
8.3. Paclitaxel
8.4. Sirolimus
8.5. Zotarolimus
9. Hydrophilic Coronary Stents Market, by Polymer Material
9.1. Introduction
9.2. Biodegradable Polymer
9.3. Durable Polymer
10. Hydrophilic Coronary Stents Market, by Stent Size
10.1. Introduction
10.2. 18 To 28 Mm
10.3. Over 28 Mm
10.4. Under 18 Mm
11. Hydrophilic Coronary Stents Market, by Clinical Application
11.1. Introduction
11.2. Acute Coronary Syndrome
11.2.1. NSTEMI
11.2.2. STEMI
11.2.3. Unstable Angina
11.3. Stable Angina
12. Hydrophilic Coronary Stents Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Center
12.3. Hospital
12.3.1. Private Hospital
12.3.2. Public Hospital
13. Hydrophilic Coronary Stents Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Hydrophilic Coronary Stents Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Hydrophilic Coronary Stents Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Apollo Endosurgery, Inc.
17.3. B. Braun Melsungen AG
17.4. Biotronik SE & Co. KG
17.5. Boston Scientific Corporation
17.6. Cook Medical LLC
17.7. Edwards Lifesciences Corporation
17.8. Endologix LLC
17.9. Hansen Medical, Inc.
17.10. Invuity, Inc.
17.11. Johnson & Johnson Services, Inc.
17.12. Lepu Medical Technology (Beijing) Co., Ltd.
17.13. Livar Stent Co., Ltd.
17.14. Medtronic plc
17.15. Meril Life Sciences Pvt. Ltd.
17.16. MicroPort Scientific Corporation
17.17. Philips Healthcare
17.18. Relievant Medsystems, Inc.
17.19. Shanghai MicroPort Medical (Group) Co., Ltd.
17.20. Shanghai Shape Memory Alloy Co., Ltd.
17.21. Siemens Healthineers AG
17.22. Stryker Corporation
17.23. Terumo Corporation
17.24. Translumina GmbH & Co. KG
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Hydrophilic Coronary Stents Market, Years Considered for the Study
FIGURE 2. Global Hydrophilic Coronary Stents Market, Research Design
FIGURE 3. Global Hydrophilic Coronary Stents Market, Research Framework
FIGURE 4. Global Hydrophilic Coronary Stents Market, Data Triangulation
FIGURE 5. Global Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Hydrophilic Coronary Stents Market Size, by Stent Type, 2025 vs 2032 (%)
FIGURE 7. Global Hydrophilic Coronary Stents Market Size, by Stent Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Hydrophilic Coronary Stents Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 9. Global Hydrophilic Coronary Stents Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Hydrophilic Coronary Stents Market Size, by Polymer Material, 2025 vs 2032 (%)
FIGURE 11. Global Hydrophilic Coronary Stents Market Size, by Polymer Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Hydrophilic Coronary Stents Market Size, by Stent Size, 2025 vs 2032 (%)
FIGURE 13. Global Hydrophilic Coronary Stents Market Size, by Stent Size, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Hydrophilic Coronary Stents Market Size, by Clinical Application, 2025 vs 2032 (%)
FIGURE 15. Global Hydrophilic Coronary Stents Market Size, by Clinical Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Hydrophilic Coronary Stents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Hydrophilic Coronary Stents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Hydrophilic Coronary Stents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Hydrophilic Coronary Stents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Hydrophilic Coronary Stents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Hydrophilic Coronary Stents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Hydrophilic Coronary Stents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Hydrophilic Coronary Stents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Hydrophilic Coronary Stents Market Segmentation & Coverage
TABLE 2. Global Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 4. Global Bare-Metal Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bare-Metal Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bare-Metal Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Drug-Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Drug-Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Drug-Eluting Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 11. Global Everolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Everolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Everolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Paclitaxel Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Paclitaxel Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Paclitaxel Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Sirolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Sirolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Sirolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Zotarolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Zotarolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Zotarolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 24. Global Biodegradable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Biodegradable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Biodegradable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Durable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Durable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Durable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 31. Global 18 To 28 Mm Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global 18 To 28 Mm Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global 18 To 28 Mm Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Over 28 Mm Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Over 28 Mm Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Over 28 Mm Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Under 18 Mm Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Under 18 Mm Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Under 18 Mm Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 41. Global Acute Coronary Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Acute Coronary Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Acute Coronary Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global NSTEMI Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global NSTEMI Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global NSTEMI Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global STEMI Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global STEMI Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global STEMI Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Unstable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Unstable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Unstable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 57. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Hydrophilic Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 79. North America Hydrophilic Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. North America Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 81. North America Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 82. North America Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 83. North America Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 84. North America Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 85. North America Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 86. North America Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. North America Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 88. Latin America Hydrophilic Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Latin America Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 90. Latin America Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 91. Latin America Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 92. Latin America Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 93. Latin America Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 94. Latin America Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 95. Latin America Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Latin America Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 97. Europe Hydrophilic Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Europe Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 99. Europe Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 100. Europe Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 101. Europe Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 102. Europe Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 103. Europe Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 104. Europe Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Europe Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 106. Middle East Hydrophilic Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Middle East Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 108. Middle East Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 109. Middle East Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 110. Middle East Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 111. Middle East Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 112. Middle East Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 113. Middle East Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Middle East Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 115. Africa Hydrophilic Coronary Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Africa Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 117. Africa Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 118. Africa Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 119. Africa Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 120. Africa Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 121. Africa Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 122. Africa Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Africa Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 124. Global Hydrophilic Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. ASEAN Hydrophilic Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. ASEAN Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 127. ASEAN Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 128. ASEAN Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 129. ASEAN Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 130. ASEAN Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 131. ASEAN Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 132. ASEAN Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. ASEAN Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 134. GCC Hydrophilic Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. GCC Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 136. GCC Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 137. GCC Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 138. GCC Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 139. GCC Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 140. GCC Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 141. GCC Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. GCC Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 143. European Union Hydrophilic Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. European Union Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 145. European Union Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 146. European Union Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 147. European Union Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 148. European Union Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 149. European Union Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 150. European Union Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. European Union Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 152. BRICS Hydrophilic Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. BRICS Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 154. BRICS Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 155. BRICS Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 156. BRICS Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 157. BRICS Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 158. BRICS Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 159. BRICS Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. BRICS Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 161. G7 Hydrophilic Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. G7 Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 163. G7 Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 164. G7 Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 165. G7 Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 166. G7 Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 167. G7 Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 168. G7 Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. G7 Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 170. NATO Hydrophilic Coronary Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. NATO Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 172. NATO Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 173. NATO Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 174. NATO Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 175. NATO Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 176. NATO Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 177. NATO Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. NATO Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 179. Global Hydrophilic Coronary Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. United States Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 181. United States Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 182. United States Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 183. United States Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 184. United States Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 185. United States Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 186. United States Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 187. United States Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. United States Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 189. Canada Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 190. Canada Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 191. Canada Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 192. Canada Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 193. Canada Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 194. Canada Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 195. Canada Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 196. Canada Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Canada Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 198. Mexico Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 199. Mexico Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 200. Mexico Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 201. Mexico Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 202. Mexico Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 203. Mexico Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 204. Mexico Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 205. Mexico Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Mexico Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 207. Brazil Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 208. Brazil Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 209. Brazil Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 210. Brazil Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 211. Brazil Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 212. Brazil Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 213. Brazil Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 214. Brazil Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Brazil Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 216. United Kingdom Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 217. United Kingdom Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 218. United Kingdom Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 219. United Kingdom Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 220. United Kingdom Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 221. United Kingdom Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 222. United Kingdom Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 223. United Kingdom Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. United Kingdom Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 225. Germany Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 226. Germany Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 227. Germany Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 228. Germany Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 229. Germany Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 230. Germany Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 231. Germany Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 232. Germany Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Germany Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 234. France Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 235. France Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 236. France Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 237. France Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 238. France Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 239. France Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 240. France Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 241. France Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. France Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 243. Russia Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 244. Russia Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 245. Russia Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 246. Russia Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 247. Russia Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 248. Russia Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 249. Russia Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 250. Russia Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Russia Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 252. Italy Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 253. Italy Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 254. Italy Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 255. Italy Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 256. Italy Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 257. Italy Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 258. Italy Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 259. Italy Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Italy Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 261. Spain Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 262. Spain Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 263. Spain Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 264. Spain Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 265. Spain Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 266. Spain Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 267. Spain Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 268. Spain Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Spain Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 270. China Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 271. China Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 272. China Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 273. China Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 274. China Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 275. China Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 276. China Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 277. China Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. China Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 279. India Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 280. India Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 281. India Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 282. India Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 283. India Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 284. India Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 285. India Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 286. India Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. India Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 288. Japan Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 289. Japan Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 290. Japan Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 291. Japan Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 292. Japan Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 293. Japan Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 294. Japan Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 295. Japan Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Japan Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 297. Australia Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 298. Australia Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 299. Australia Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 300. Australia Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 301. Australia Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 302. Australia Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 303. Australia Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 304. Australia Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Australia Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 306. South Korea Hydrophilic Coronary Stents Market Size, 2017-2032 (USD Million)
TABLE 307. South Korea Hydrophilic Coronary Stents Market Size, by Stent Type, 2017-2032 (USD Million)
TABLE 308. South Korea Hydrophilic Coronary Stents Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 309. South Korea Hydrophilic Coronary Stents Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 310. South Korea Hydrophilic Coronary Stents Market Size, by Stent Size, 2017-2032 (USD Million)
TABLE 311. South Korea Hydrophilic Coronary Stents Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 312. South Korea Hydrophilic Coronary Stents Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 313. South Korea Hydrophilic Coronary Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. South Korea Hydrophilic Coronary Stents Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 315. Global Hydrophilic Coronary Stents Market Share, by Key Player, 2025
TABLE 316. Global Hydrophilic Coronary Stents Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Apollo Endosurgery, Inc.
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Endologix LLC
  • Hansen Medical, Inc.
  • Invuity, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Livar Stent Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Philips Healthcare
  • Relievant Medsystems, Inc.
  • Shanghai MicroPort Medical (Group) Co., Ltd.
  • Shanghai Shape Memory Alloy Co., Ltd.
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Translumina GmbH & Co. KG

Related Topics

Related Reports

Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2026-2032 - Product Image

Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market - Global Forecast 2026-2032 - Product Image

Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2026-2034 - Product Image

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Bioresorbable Coronary Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Bioresorbable Coronary Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.